NEW
Stock Screener with Intrinsic Value
Royalty Pharma plc (RPRX)
Last Price$30.8(0.6%)
Market Cap$13.8B
(2.5%)
Industry median - 13.2%
5Y Historical average - 30.1%
58.4%
Industry median - 1.0%
5Y Historical average - 36.0%
5,821.2%
Industry median - (20.6%)
5Y Historical average - 420.1%
28.6%
Industry median - (1.2%)
5Y Historical average - 52.2%
RPRX Growth Rating
Crunching data... Almost there!
RPRX Growth Metrics
Crunching data... Almost there!
Competing with RPRX Growth
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Royalty Pharma plc (RPRX) revenue growth?
The Royalty Pharma plc (RPRX) revenue growth is (2.5%), which is lower than the industry median of 13.2% and the 5-year historical average of 30.1%.
What is the Royalty Pharma plc (RPRX) operating income growth?
The Royalty Pharma plc (RPRX) operating income growth is 58.4%, compared to the industry median of 1.0% and the 5-year historical average of 36.0%.
What is the Royalty Pharma plc (RPRX) EPS (Earnings Per Share) growth?
The Royalty Pharma plc (RPRX) EPS growth is 5,821.2%, compared to the industry median of (20.6%) and the 5-year historical average of 420.1%.
What is the Royalty Pharma plc (RPRX) Free Cash Flow (FCF) growth?
The Royalty Pharma plc (RPRX) Free Cash Flow growth is 28.6%, compared to the industry median of (1.2%) and the 5-year historical average of 52.2%.